AK138D1

· Akeso

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AK138D1, covering 2025-03-06 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AK138D1 in Advanced Malignant Tumors [Phase 1]